FDA ENDOSSEOUS IMPLANT GUIDANCE DOCUMENTS WILL BE CONSOLIDATED, AGENCY SAYS; DENTAL PANEL MEMBERS RECOMMEND ONE GUIDANCE EACH FOR 510(K)s AND PMAs
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to consolidate the approximately dozen guidances it has developed on endosseous implants as pan of its effort to finalize a classification scheme for the dental devices, the agency indicated at a Dec. 7 meeting of its Dental Products Panel in Washington, D.C.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.